Röcken C, Höfler H, Hummel M, Meyermann R, Zietz C, Schirmacher P
Institut für Pathologie, Christian-Albrechts-Universität Kiel, Arnold-Heller-Strasse 3, Kiel, Germany.
Pathologe. 2013 Sep;34(5):466-75. doi: 10.1007/s00292-013-1793-y.
Clinical studies and preclinical investigations are essential in order to test new therapies and diagnostics with the aim of sustained improvement in the treatment of patients. Fortunately, the number of clinical studies is continuously increasing and pathology and tissue-based research are included more often. The German Society for Pathology (DGP) and the pathologists it represents want to and can support this process and our clinical partners as best as possible as an equal partner. With our technologies and our specific expertise we can make a substantial contribution to the quality and the success of preclinical investigations, clinical studies and implementation of the results into clinical pathological diagnostics. In order to support this process the DGP has formulated a statement on the participation and support of clinical studies and other scientific investigations.
为了测试新的治疗方法和诊断手段，以期持续改善患者治疗效果，临床研究和临床前调查至关重要。幸运的是，临床研究的数量在不断增加，病理学和基于组织的研究也越来越多地被纳入其中。德国病理学会（DGP）及其代表的病理学家希望并能够作为平等伙伴，尽可能地支持这一进程以及我们的临床合作伙伴。凭借我们的技术和专业特长，我们可以为临床前调查、临床研究以及将研究结果应用于临床病理诊断的质量和成功做出重大贡献。为了支持这一进程，DGP就参与和支持临床研究及其他科学调查制定了一项声明。
